Accelerating Small Molecule Advancements: The Power of Collaboration Between CDMOs and Biotechs

The increasing number of breakthroughs in small molecule drug development are exciting, but corresponding workflows are complex and require much more tailored approaches to ensure successful upstream and downstream processing, drug approvals and commercialization.